Which is better, HALO or LMAT?

On the Buffett-Fit framework, LeMaitre Vascular, Inc. (LMAT) currently grades higher than HALO — 77/100 (B grade) vs 79/100 (B). That said, "better" depends on which framework you trust — HALO wins on Warren Buffett, Charlie Munger, and Terry Smith; LMAT wins on Benjamin Graham, Philip Fisher, Peter Lynch, and Joel Greenblatt. The full pillar breakdown is on this page.

Should I buy HALO or LMAT?

This page is an educational comparison, not investment advice. Both HALO and LMAT are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is HALO better than LMAT for value investing?

The two are close on the headline Buffett-Fit score (79/100 vs 77/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between HALO and LMAT on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). HALO currently scores 79/100 (B grade); LMAT scores 77/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, HALO or LMAT?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. HALO and LMAT are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, HALO or LMAT?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are HALO and LMAT both Healthcare stocks?

Yes — both Halozyme Therapeutics, Inc. (HALO) and LeMaitre Vascular, Inc. (LMAT) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this HALO vs LMAT comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Halozyme Therapeutics

LeMaitre Vascular

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

HALO

Market cap

$8.1B

Sector

Healthcare

LMAT

LeMaitre Vascular

Market cap

$2.23B

Sector

Healthcare

Overall winner

LeMaitre Vascular LMAT

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	HALO	LMAT	Winner
Warren Buffett	79B	77B	HALO
Benjamin Graham	83A	89A	LMAT
Philip Fisher	65B	81C	LMAT
Peter Lynch	53D	67B	LMAT
Joel Greenblatt	40D	56D	LMAT
Charlie Munger	80C	68D	HALO
Terry Smith	84A	69D	HALO

Side-by-side metrics

Metric	HALO	LMAT
Market cap	$8.1B	$2.23B
P/E (TTM)	24.0x	37.1x
EV/EBIT	10.2x	36.6x
ROIC (TTM)	23.65%	9.43%
Gross margin	81.24%	72.39%
Net margin	23.13%	24.35%
Revenue CAGR 5y	33.23%	12.75%
EPS CAGR 5y	-1.98%	19.04%
Debt / Equity	1.0x	0.5x
Dividend yield	0.0%	0.84%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

HALO leads on

Market cap$8.1Bvs $2.23B+72%
EV/EBIT10.2xvs 36.6x+72%
Revenue CAGR 5y33.23%vs 12.75%+62%
ROIC (TTM)23.65%vs 9.43%+60%

LMAT leads on

EPS CAGR 5y19.04%vs -1.98%+110%
Dividend yield0.84%vs 0.0%+100%
Debt / Equity0.5xvs 1.0x+51%
Net margin24.35%vs 23.13%+5%

More like HALO

HALO vs RMD HALO vs LLY HALO vs UTHR HALO vs HAE HALO vs IDXX HALO vs CPRX

More like LMAT

LMAT vs RMD LMAT vs LLY LMAT vs UTHR LMAT vs HAE LMAT vs IDXX LMAT vs CPRX

Read the full Buffett-Brain analysis for HALO Read the full Buffett-Brain analysis for LMAT

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Halozyme Therapeutics

LeMaitre Vascular

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

HALO

Halozyme Therapeutics

Market cap

$8.1B

Sector

Healthcare

LMAT

LeMaitre Vascular

Market cap

$2.23B

Sector

Healthcare

Overall winner

LeMaitre Vascular LMAT

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	HALO	LMAT	Winner
Warren Buffett	79B	77B	HALO
Benjamin Graham	83A	89A	LMAT
Philip Fisher	65B	81C	LMAT
Peter Lynch	53D	67B	LMAT
Joel Greenblatt	40D	56D	LMAT
Charlie Munger	80C	68D	HALO
Terry Smith	84A	69D	HALO

Side-by-side metrics

Metric	HALO	LMAT
Market cap	$8.1B	$2.23B
P/E (TTM)	24.0x	37.1x
EV/EBIT	10.2x	36.6x
ROIC (TTM)	23.65%	9.43%
Gross margin	81.24%	72.39%
Net margin	23.13%	24.35%
Revenue CAGR 5y	33.23%	12.75%
EPS CAGR 5y	-1.98%	19.04%
Debt / Equity	1.0x	0.5x
Dividend yield	0.0%	0.84%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

HALO leads on

Market cap$8.1Bvs $2.23B+72%
EV/EBIT10.2xvs 36.6x+72%
Revenue CAGR 5y33.23%vs 12.75%+62%
ROIC (TTM)23.65%vs 9.43%+60%

LMAT leads on

EPS CAGR 5y19.04%vs -1.98%+110%
Dividend yield0.84%vs 0.0%+100%
Debt / Equity0.5xvs 1.0x+51%
Net margin24.35%vs 23.13%+5%

More like HALO

HALO vs RMD HALO vs LLY HALO vs UTHR HALO vs HAE HALO vs IDXX HALO vs CPRX

More like LMAT

LMAT vs RMD LMAT vs LLY LMAT vs UTHR LMAT vs HAE LMAT vs IDXX LMAT vs CPRX

Read the full Buffett-Brain analysis for HALO Read the full Buffett-Brain analysis for LMAT

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.